AOH1996 for the Treatment of Refractory Solid Tumors

NCT05227326 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Refractory Malignant Solid Neoplasm
Osteosarcoma
Leiomyosarcomas
Synovial Sarcomas
Ovarian Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer

Interventions

DRUG: PCNA Inhibitor AOH1996

Sponsor

City of Hope Medical Center

Collaborators

[object Object]